Steven Cohen's position in Dianthus Therapeutics is currently worth $52.8M. That's 0.08% of their equity portfolio (268th largest holding). The investor owns 1.54% of the outstanding Dianthus Therapeutics stock. The first Dianthus Therapeutics trade was made in Q1 2024. Since then Steven Cohen bought shares three more times and sold shares on five occasions. The stake costed the investor $15.1M, netting the investor a gain of 249% so far.